LexDanaLexDanabeta
Inventor

Tiina Marttila

Inventor
DE

Overview

1→
Patents
2026
Patent span
Chemistry
Primary field (CPC C)

Patents· 1 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
C12NMicroorganisms or enzymes25%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms25%
G01NInvestigating or analysing materials by determining their chemical or physical properties25%
PatentTitleYear
12,516,381Method for predicting the clinical response of oncolytic parvovirus H1 (H-1PV) treatment in a patient suspected of suffering from cancer by measuring the expression levels of laminins and/or galectins as biomarkers in a patient's sample2026

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2026Patents assigned to DEUTSCHES KREBS FORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS (1)· patent assignee history
2026Patents assigned to DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS (1)· patent assignee history
2026Based in DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DEUTSCHES KREBS FORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS12026
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS12026
Locations
LocationPatentsSpan
DE12026